Trefoil factor 3 contributes to the malignancy of glioma via regulating HIF-1&#x03B1;

Shuo Diao; Qianqian Zheng; Jian Gao; Yiqun Yao; Siyang Ren; Yongjian Liu; Yinghui Xu

doi:10.18632/oncotarget.20010

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Trefoil factor 3 contributes to the malignancy of glioma via regulating HIF-1α

Shuo Diao, Qianqian Zheng, Jian Gao, Yiqun Yao, Siyang Ren, Yongjian Liu and Yinghui Xu _

PDF | HTML | How to cite

Oncotarget. 2017; 8:76770-76782. https://doi.org/10.18632/oncotarget.20010

Metrics: PDF 1462 views | HTML 2101 views | ?

Abstract

Shuo Diao1, Qianqian Zheng2, Jian Gao3, Yiqun Yao1, Siyang Ren1, Yongjian Liu4 and Yinghui Xu1

1Department of Neurosurgery, First Affiliated Hospital, Dalian Medical University, Dalian, People’s Republic of China

2Department of Pathophysiology, Basic Medical College, China Medical University, Shenyang, People’s Republic of China

3Center of Laboratory Technology and Experimental Medicine, China Medical University, Shenyang, People’s Republic of China

4Department of Interventional Therapy, First Affiliated Hospital, Dalian Medical University, Dalian, People’s Republic of China

Correspondence to:

Yinghui Xu, email: [email protected]

Keywords: TFF3, glioblastoma, HIF-1α, proliferation, apoptosis

Received: March 14, 2017 Accepted: June 27, 2017 Published: August 07, 2017

ABSTRACT

Trefoil factor 3 (TFF3) plays significant roles in several solid tumors. However, the expression pattern and function of TFF3 in glioblastoma (GBM) have not been reported. Here, we report that expression level of TFF3 significantly elevated in glioma and correlated with the prognosis of glioma patients. Then we found TFF3 promotes proliferation, invasion, and migration and inhibits apoptosis of glioma cells in vitro, and delayed tumor progression in subcutaneous xenograft nude mice, and prolonged the median survival time in orthotopic xenograft mice. Moreover, knockdown of TFF3 reduced the expression of HIF-1α through a hypoxia-independent manner. These findings suggest that targeting TFF3 may offer a novel strategy for therapeutic intervention of malignant gliomas.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20010

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Trefoil factor 3 contributes to the malignancy of glioma via regulating HIF-1α

Abstract